Generic Name: Mycophenolate sodium
Brand Name: Myfortic
Manufacturer: Novartis Pharmaceuticals Canada Inc.
Therapeutic Area: Organ rejection in allogeneic renal transplants, Prophylaxis
Indications: Organ rejection in allogeneic renal transplants, Prophylaxis
Submission Type: Initial
Project Status: Complete
Date Recommendation Issued: July 8, 2005
Recommendation Type: List in a similar manner to other drugs in class